Prognosis of gamma-glutamylcysteine synthetase deficiency, gamma-glutamyl transpeptidase deficiency, 5-oxoprolinase deficiency and dipeptidase deficiency is unclear and difficult to predict as very few patients have been reported worldwide
doi: 10.3389/FENDO.2023.1215356 94 YounesSTMaedaKJSasserJRyanMJ
has segmented the GLP-1 receptor agonist market Product Application Route of Administration Distribution Channel Regional
Major adverse cardiovascular events (MACE)including cardiovascular death, non-fatal myocardial infarction, and non-fatal strokewere not increased with Zepbound treatment, though the trial was not specifically powered to evaluate cardiovascular outcomes
The honest answer is that it depends, and it depends most on whether you are actually deficient
By keeping blood sugar levels stable and promoting fat loss, tirzepatide helps reduce inflammation, which is a contributing factor to cardiovascular problems